Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
216.7 USD | -1.03% | -3.48% | -8.24% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.24% | 11.28B | |
+64.45% | 62.59B | |
-1.70% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.93% | 26.21B | |
-21.69% | 19.09B | |
+4.42% | 13.08B | |
+25.62% | 12.26B | |
+28.34% | 12.05B |
- Stock Market
- Equities
- CRL Stock
- News Charles River Laboratories International, Inc.
- JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280